Press release content from Globe Newswire. The AP news staff was not involved in its creation. AB2 Bio Appoints Dr Djordje Filipovic as Chief Commercial Officer AB2 BioDecember 16, 2020 GMT Will drive commercial strategy and execution of Tadekinig alfa, currently in Phase 3 Joins AB2 Bio from Novartis and has extensive commercial and strategic experience LAUSANNE, Switzerland, Dec. 16, 2020 (GLOBE NEWSWIRE) -- AB2 Bio Ltd., a Phase 3 clinical-stage biotech company developing innovative therapies for the treatment of severe systemic autoinflammatory diseases, today announced the appointment...